RNTX (Rein Therapeutics) FFO


RNTX Rein Therapeutics Inc RNTX
30 GF Score
Price $1.00
! 1 Warning Sign
View Full Analysis

What is Rein Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

RNTX
30GF Score
Rein Therapeutics Inc RNTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rein Therapeutics Business Description

Address 12407 North Mopac Expressway, Suite 250, No.390, Austin, TX, USA, 78758
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.
30GF Score

Get the complete analysis for RNTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price